The cytoskeleton is a complex set of proteins which provides stability and structure to all cells. There is increasing evidence that the cytoskeleton can be rapidly modified in response to signals from membrane bound receptors. Such signals induce changes in the cytoskeleton which are reflected in alterations in cell shape, rigidity, mobility, adhesiveness, and the ability of intracellular proteins to interact with the cytoskeleton. One form of signaling which is believed to be important in modifying functions is phosphorylation. One of the cytoskeleton proteins that may be an important link between membrane receptors and the cytoskeleton is paxillin. Paxillin is a focal contact (actin binding) protein with a MW of 68 kDa which can bind to vinculin. Paxillin was initially identified in Rous Sarcoma Virus transformed chick embryo fibroblasts in a blind screening of monoclonal antibodies to proteins containing phosphotyrosine. Up to 20-30% of paxillin is phosphorylated on tyrosine residues in RSV transformed cells, and paxillin has been shown to be transiently tyrosine phosphorylated in fibroblasts in response to epidermal growth factor. Thus, paxillin has been suggested to be a direct link between growth factor receptors and oncogene (v-SRC) which activate tyrosine kinases and the cytoskeleton. Since many growth factors and oncogenes alter the structure of the cytoskeleton in cells of many different lineages, paxillin may play an important role in signal transduction. Recent data shows paxillin is immediately phosphorylated after stimulation of hematopoietic cells with various cytokines and the oncogene p210BCR/ABL (Philadelphia chromosome in chronic myelogenous leukemia). Also, growth factor and oncogene stimulation causes paxillin to associate with vinculin and with several unidentified intracellular proteins. In an effort to understand the structure and function of paxillin, partial cDNA's encoding this protein have been cloned. It is proposed here in this project to determine the structure of paxillin and paxillin related proteins by cloning the cDNA's encoding these proteins. Also, to generate antibodies to various domains of paxillin. Finally, to determine the regions of paxillin necessary to bind vinculin and determine the effects of tyrosine phosphorylation of paxillin on vinculin binding. These studies will help elucidate the function of paxillin in the cytoskeleton and will provide a model system to study the mechanisms through which cell membrane receptors and oncogenes send signals to the cytoskeleton.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA060821-02
Application #
2101588
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1993-08-15
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Sattler, M; Salgia, R; Shrikhande, G et al. (1997) Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J Biol Chem 272:14320-6
Uemura, N; Salgia, R; Li, J L et al. (1997) The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins. Leukemia 11:376-85
Manie, S N; Beck, A R; Astier, A et al. (1997) Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 272:4230-6
Manie, S N; Sattler, M; Astier, A et al. (1997) Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation. Exp Hematol 25:45-50
Sattler, M; Salgia, R; Okuda, K et al. (1996) The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 12:839-46
Salgia, R; Pisick, E; Sattler, M et al. (1996) p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene. J Biol Chem 271:25198-203
Salgia, R; Avraham, S; Pisick, E et al. (1996) The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem 271:31222-6
Salgia, R; Sattler, M; Pisick, E et al. (1996) p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl. Exp Hematol 24:310-3
Salgia, R; Li, J L; Lo, S H et al. (1995) Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 270:5039-47
Salgia, R; Uemura, N; Okuda, K et al. (1995) CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem 270:29145-50

Showing the most recent 10 out of 11 publications